Hyperbaric Oxygen Therapy
(HBOT)

Hyperbaric Oxygen Therapy has been shown to increase oxygen saturation to tissues and increase the amount of stem cell production and circulation. Hyperbaric Oxygen Therapy is utilized to increase oxygenation, helping to promote healing and increase neurological stamina. This allows for the greatest potential for healing in the brain. 

Hyperbaric oxygen therapy (HBOT) is the medical use of oxygen in a pressurized environment, at a level higher than 1 atmosphere absolute (ATA). Increased pressure allows for oxygen to dissolve and saturate the blood plasma (independent of hemoglobin/red blood cells), which yields a broad variety of positive physiological, biochemical and cellular effects. This noninvasive therapy is the most trusted way to increase oxygen levels to all organs of the body. The typical treatment lasts for 60-90 minutes, during which the patient lies down and breathes normally. HBOT has been demonstrated in several clinical studies to enhance the body’s innate ability to repair and regenerate. It is used as an adjunct therapy to complement and enhance the healing process in both chronic and acute conditions.

Research:

Hyperbaric oxygen therapy for brain injury, cerebral palsy, and stroke.

Hyperbaric oxygen – its mechanisms and efficacy

Hyperbaric oxygen therapy may improve symptoms in autistic children

Hyperbaric Oxygen Pretreatment Improves Cognition and Reduces Hippocampal Damage Via p38 Mitogen-Activated Protein Kinase in a Rat Model

Randomized trial of hyperbaric oxygen therapy for children with autism

Study the effect of hyperbaric oxygen therapy in Egyptian autistic children: A clinical trial

Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson’s disease in rats

Hyperbaric Oxygen and Ginkgo Biloba Extract Ameliorate Cognitive and Memory Impairment via Nuclear Factor Kappa-B Pathway in Rat Model of Alzheimer’s Disease.

Hyperbaric oxygen therapy for multiple sclerosis.

Regional gray matter atrophy and neuropsychologcal problems in relapsing-remitting multiple sclerosis.